Clinical utility of the risperidone formulations in the management of schizophrenia
Vishal Madaan1, Durga P Bestha2, Venkata Kolli2, Saurabh Jauhari2, Roger C Burket1 1University of Virginia Health System, Charlottesville, VA, USA; 2Creighton University Medical Center, Omaha, NE, USA Abstract: Risperidone is one of the early second-generation antipsychotics that came into the limel...
Guardado en:
Autores principales: | Madaan V, Bestha DP, Kolli VB, Jauhari S, Burket RC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e22fb417ecc4272945dff6c78e223b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan V, et al.
Publicado: (2013) -
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Hong Liu-Seifert, et al.
Publicado: (2009) -
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Jeffrey R Bishop, et al.
Publicado: (2008) -
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs L, et al.
Publicado: (2013) -
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã M, et al.
Publicado: (2011)